Amgen to Present Long-Term Outcomes for Lumakras (Sotorasib) In KRAS G12C-Mutated NSCLC at Aacr 2022
Late-Breaking Oral Presentation Includes Two-Year Follow-Up Data from CodeBreaK 100 Study - the Most Advanced KRAS G12C Clinical Dataset
Pre-Clinical…